Statins Market 2027 By Product Class, Application, End User | The Insight Partners

Statins Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product Class (atorvastatin (Lipitor and others), fluvastatin (Lescol, Canef, and Vastin), lovastatin (Mevacor and others), pravastatin (Pravachol), rosuvastatin (Crestor), simvastatin (Zocor), pitavastatin (Livalo)); Application (cardiovascular diseases (heart strokes andattacks), lifestyle diseases (obesity, diabetes, and inflammation), others); End User (hospitals, clinics, others)

Report Code: TIPRE00011966 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Statins are lipid-lowering agents or medications used in the treatment of high lipid levels. These are often referred to as high cholesterol found in the blood. The primary function of statins is to lower blood cholesterol and prevent atherosclerosis. According to studies, statins have reduced heart attacks and strokes by 25% to 35%. Statins recommended by health care practitioners work well for patients with balanced nutritious food and exercise.

MARKET DYNAMICS

The statins market is driving due to the rise in health care expenditure, technological advancements. However, increase in demand for effective treatment alternatives acts as a major restraint of the market. Social and economic factors also hamper the global statins market. Moreover, the increase in incidence of lifestyle diseases also boost the growth of the market for statins.

MARKET SCOPE

The "Statins Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of statins market with detailed market segmentation by product class, application and end user. The statins market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in statins market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The statins market is segmented on the basis of product class, application and end user. Based on product class, the market is segmented as atorvastatin (Lipitor & others), fluvastatin (Lescol, Canef, and Vastin), lovastatin (Mevacor & others), pravastatin (Pravachol), rosuvastatin (Crestor), simvastatin (Zocor), and pitavastatin (Livalo). On the basis of application, the market is categorized as cardiovascular diseases (heart strokes & attacks), lifestyle diseases (obesity, diabetes, and inflammation), and others. On the basis of end user, the market is categorized as hospitals, clinics, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the statins market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The statins market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting statins market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the statins market in these regions.




Get more information on this report :

MARKET PLAYERS


The report covers key developments in the statins market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from statins market are anticipated to have lucrative growth opportunities in the future with the rising demand for statins in the global market. Below mentioned is the list of few companies engaged in the statins market.

The report also includes the profiles of key players in statins market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Amgen
  •   AstraZeneca
  •   Aurbindo Pharma
  •   Biocon
  •   Concord Biotech
  •   GlaxoSmithKline plc,
  •   Merck & Co., Inc.
  •   Pfizer, Inc.


The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Statins Market - By Product Class
1.3.2 Statins Market - By Application
1.3.3 Statins Market - By End User
1.3.4 Statins Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. STATINS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. STATINS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. STATINS MARKET - GLOBAL MARKET ANALYSIS
6.1. STATINS - GLOBAL MARKET OVERVIEW
6.2. STATINS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. STATINS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT CLASS
7.1. OVERVIEW
7.2. PRODUCT CLASS MARKET FORECASTS AND ANALYSIS
7.3. ATORVASTATIN (LIPITOR AND OTHERS)
7.3.1. Overview
7.3.2. atorvastatin (Lipitor and others) Market Forecast and Analysis
7.4. FLUVASTATIN (LESCOL
7.4.1. Overview
7.4.2. fluvastatin (Lescol Market Forecast and Analysis
7.5. CANEF
7.5.1. Overview
7.5.2. Canef Market Forecast and Analysis
7.6. AND VASTIN)
7.6.1. Overview
7.6.2. and Vastin) Market Forecast and Analysis
7.7. LOVASTATIN (MEVACOR AND OTHERS)
7.7.1. Overview
7.7.2. lovastatin (Mevacor and others) Market Forecast and Analysis
7.8. PRAVASTATIN (PRAVACHOL)
7.8.1. Overview
7.8.2. pravastatin (Pravachol) Market Forecast and Analysis
7.9. ROSUVASTATIN (CRESTOR)
7.9.1. Overview
7.9.2. rosuvastatin (Crestor) Market Forecast and Analysis
7.10. SIMVASTATIN (ZOCOR)
7.10.1. Overview
7.10.2. simvastatin (Zocor) Market Forecast and Analysis
7.11. PITAVASTATIN (LIVALO)
7.11.1. Overview
7.11.2. pitavastatin (Livalo) Market Forecast and Analysis
8. STATINS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. CARDIOVASCULAR DISEASES (HEART STROKES ANDATTACKS)
8.3.1. Overview
8.3.2. cardiovascular diseases (heart strokes andattacks) Market Forecast and Analysis
8.4. LIFESTYLE DISEASES (OBESITY
8.4.1. Overview
8.4.2. lifestyle diseases (obesity Market Forecast and Analysis
8.5. DIABETES
8.5.1. Overview
8.5.2. diabetes Market Forecast and Analysis
8.6. AND INFLAMMATION)
8.6.1. Overview
8.6.2. and inflammation) Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. others Market Forecast and Analysis
9. STATINS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. hospitals Market Forecast and Analysis
9.4. CLINICS
9.4.1. Overview
9.4.2. clinics Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. others Market Forecast and Analysis
10. STATINS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Statins Market Overview
10.1.2 North America Statins Market Forecasts and Analysis
10.1.3 North America Statins Market Forecasts and Analysis - By Product Class
10.1.4 North America Statins Market Forecasts and Analysis - By Application
10.1.5 North America Statins Market Forecasts and Analysis - By End User
10.1.6 North America Statins Market Forecasts and Analysis - By Countries
10.1.6.1 United States Statins Market
10.1.6.1.1 United States Statins Market by Product Class
10.1.6.1.2 United States Statins Market by Application
10.1.6.1.3 United States Statins Market by End User
10.1.6.2 Canada Statins Market
10.1.6.2.1 Canada Statins Market by Product Class
10.1.6.2.2 Canada Statins Market by Application
10.1.6.2.3 Canada Statins Market by End User
10.1.6.3 Mexico Statins Market
10.1.6.3.1 Mexico Statins Market by Product Class
10.1.6.3.2 Mexico Statins Market by Application
10.1.6.3.3 Mexico Statins Market by End User
10.2. EUROPE
10.2.1 Europe Statins Market Overview
10.2.2 Europe Statins Market Forecasts and Analysis
10.2.3 Europe Statins Market Forecasts and Analysis - By Product Class
10.2.4 Europe Statins Market Forecasts and Analysis - By Application
10.2.5 Europe Statins Market Forecasts and Analysis - By End User
10.2.6 Europe Statins Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Statins Market
10.2.6.1.1 Germany Statins Market by Product Class
10.2.6.1.2 Germany Statins Market by Application
10.2.6.1.3 Germany Statins Market by End User
10.2.6.2 France Statins Market
10.2.6.2.1 France Statins Market by Product Class
10.2.6.2.2 France Statins Market by Application
10.2.6.2.3 France Statins Market by End User
10.2.6.3 Italy Statins Market
10.2.6.3.1 Italy Statins Market by Product Class
10.2.6.3.2 Italy Statins Market by Application
10.2.6.3.3 Italy Statins Market by End User
10.2.6.4 Spain Statins Market
10.2.6.4.1 Spain Statins Market by Product Class
10.2.6.4.2 Spain Statins Market by Application
10.2.6.4.3 Spain Statins Market by End User
10.2.6.5 United Kingdom Statins Market
10.2.6.5.1 United Kingdom Statins Market by Product Class
10.2.6.5.2 United Kingdom Statins Market by Application
10.2.6.5.3 United Kingdom Statins Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Statins Market Overview
10.3.2 Asia-Pacific Statins Market Forecasts and Analysis
10.3.3 Asia-Pacific Statins Market Forecasts and Analysis - By Product Class
10.3.4 Asia-Pacific Statins Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Statins Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Statins Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Statins Market
10.3.6.1.1 Australia Statins Market by Product Class
10.3.6.1.2 Australia Statins Market by Application
10.3.6.1.3 Australia Statins Market by End User
10.3.6.2 China Statins Market
10.3.6.2.1 China Statins Market by Product Class
10.3.6.2.2 China Statins Market by Application
10.3.6.2.3 China Statins Market by End User
10.3.6.3 India Statins Market
10.3.6.3.1 India Statins Market by Product Class
10.3.6.3.2 India Statins Market by Application
10.3.6.3.3 India Statins Market by End User
10.3.6.4 Japan Statins Market
10.3.6.4.1 Japan Statins Market by Product Class
10.3.6.4.2 Japan Statins Market by Application
10.3.6.4.3 Japan Statins Market by End User
10.3.6.5 South Korea Statins Market
10.3.6.5.1 South Korea Statins Market by Product Class
10.3.6.5.2 South Korea Statins Market by Application
10.3.6.5.3 South Korea Statins Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Statins Market Overview
10.4.2 Middle East and Africa Statins Market Forecasts and Analysis
10.4.3 Middle East and Africa Statins Market Forecasts and Analysis - By Product Class
10.4.4 Middle East and Africa Statins Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Statins Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Statins Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Statins Market
10.4.6.1.1 South Africa Statins Market by Product Class
10.4.6.1.2 South Africa Statins Market by Application
10.4.6.1.3 South Africa Statins Market by End User
10.4.6.2 Saudi Arabia Statins Market
10.4.6.2.1 Saudi Arabia Statins Market by Product Class
10.4.6.2.2 Saudi Arabia Statins Market by Application
10.4.6.2.3 Saudi Arabia Statins Market by End User
10.4.6.3 U.A.E Statins Market
10.4.6.3.1 U.A.E Statins Market by Product Class
10.4.6.3.2 U.A.E Statins Market by Application
10.4.6.3.3 U.A.E Statins Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Statins Market Overview
10.5.2 South and Central America Statins Market Forecasts and Analysis
10.5.3 South and Central America Statins Market Forecasts and Analysis - By Product Class
10.5.4 South and Central America Statins Market Forecasts and Analysis - By Application
10.5.5 South and Central America Statins Market Forecasts and Analysis - By End User
10.5.6 South and Central America Statins Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Statins Market
10.5.6.1.1 Brazil Statins Market by Product Class
10.5.6.1.2 Brazil Statins Market by Application
10.5.6.1.3 Brazil Statins Market by End User
10.5.6.2 Argentina Statins Market
10.5.6.2.1 Argentina Statins Market by Product Class
10.5.6.2.2 Argentina Statins Market by Application
10.5.6.2.3 Argentina Statins Market by End User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL STATINS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Rest of the World
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. STATINS MARKET, KEY COMPANY PROFILES
13.1. AMGEN
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ASTRAZENECA
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. AURBINDO PHARMA
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. BIOCON
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. CONCORD BIOTECH
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. GLAXOSMITHKLINE PLC,
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. MERCK AND CO., INC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. PFIZER, INC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Amgen
2. AstraZeneca
3. Aurbindo Pharma
4. Biocon
5. Concord Biotech
6. GlaxoSmithKline plc,
7. Merck & Co., Inc.
8. Pfizer, Inc.
TIPRE00011966
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking